Literature DB >> 4674910

Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes.

R E Rocklin, H G Remold, J R David.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4674910     DOI: 10.1016/0008-8749(72)90070-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  20 in total

1.  Big and little forms of osteoclast activating factor.

Authors:  G R Mundy; L G Raisz; J L Shapiro; J G Bandelin; R J Turcotte
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Partial purification and characterization of the human lymphocyte colony enhancing factor (LCEF).

Authors:  A Zeevi; I Goldman; L A Rozenszajn
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

3.  Mononuclear leucocyte chemotaxis in the chicken. Definition of a phylogenetically specific lymphokine.

Authors:  L C Altman; H Kirchner
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

Review 4.  Human lymphoid cell lines: models for immunological analysis.

Authors:  P R Glade; P S Papageorgiou
Journal:  In Vitro       Date:  1973 Nov-Dec

5.  Production of macrophage migration inhibition factors by virus-infected cell cultures.

Authors:  T D Flanagan; T Yoshida; S Cohen
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

6.  The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.

Authors:  A W Preece; P A Light
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

7.  Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.

Authors:  A R Rabson; H J Koornhof
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

8.  Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.

Authors:  R A Luben; G R Mundy; C L Trummel; L G Raisz
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

9.  Biological and clinical relevance of human macrophage migration inhibitory factor (MIF).

Authors:  L H Block; G Ruhenstroth-Bauer
Journal:  Blut       Date:  1979-02-19

10.  Canine migration inhibitory factor: effect of Corynebacterium parvum administration.

Authors:  M S Pineiro; C A Bowles; E C Cutchins; M I Bull
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.